Name: Designing a Universal Nasal Drug Delivery Platform to Enhance Bioavailability of Challenging Small Molecules
Start: 2026-05-13T11:20:00-0400
End: 2026-05-13T11:45:00-0400

Designing a Universal Nasal Drug Delivery Platform to Enhance Bioavailability of Challenging Small Molecules

Wednesday May 13, 2026 11:20am - 11:45am EDT

Crowne Plaza Princeton - Conference Center by IHG

Nasal drug delivery is emerging as a powerful alternative for small molecules limited by poor bioavailability. This session explores the design of a universal nasal delivery platform engineered to overcome solubility, permeability, and stability challenges. Discover how smart formulation and device strategies can unlock rapid absorption, consistent exposure, and new therapeutic potential for molecules once considered undeliverable.

Speakers

Deb Das, PhD

Senior Associate Director & Science Fellow, Research and Development, Bayer

Debanjan (Deb), is a drug delivery scientist and an innovation-driven technical manager with over 19 years of product development experience in driving projects from concept to commercialization. He has marketed more than 40 commercial products in US (small molecules & biologics... Read More →

Wednesday May 13, 2026 11:20am - 11:45am EDT
Crowne Plaza Princeton - Conference Center by IHG 900 Scudders Mill Rd, Plainsboro Township, NJ 08536, USA

General Session

2026 CRBE Summit East - Innovations in Controlled Release, Bioavailability Enhan

Deb Das, PhD

Get help with the event

2026 CRBE Summit East - Innovations in Controlled Release, Bioavailability Enhan

Deb Das, PhD

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Get help with the event